125.05
price up icon0.63%   0.78
after-market アフターアワーズ: 125.14 0.09 +0.07%
loading
前日終値:
$124.27
開ける:
$124.63
24時間の取引高:
375.71K
Relative Volume:
0.65
時価総額:
$7.57B
収益:
$3.99B
当期純損益:
$463.16M
株価収益率:
17.61
EPS:
7.1
ネットキャッシュフロー:
$1.10B
1週間 パフォーマンス:
+2.10%
1か月 パフォーマンス:
+1.69%
6か月 パフォーマンス:
+11.38%
1年 パフォーマンス:
-0.41%
1日の値動き範囲:
Value
$123.67
$125.62
1週間の範囲:
Value
$120.39
$126.12
52週間の値動き範囲:
Value
$99.06
$134.17

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1178)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,800
Name
Twitter
@jazzpharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

JAZZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
125.05 7.57B 3.99B 463.16M 1.10B 7.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
08:03 AM

Leerink Partnrs Issues Optimistic Forecast for JAZZ Earnings - MarketBeat

08:03 AM
pulisher
05:43 AM

Jazz Pharmaceuticals (NASDAQ:JAZZ) investors are sitting on a loss of 14% if they invested five years ago - Simply Wall St

05:43 AM
pulisher
Jan 29, 2025

KBC Group NV Has $29.10 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 29, 2025
pulisher
Jan 27, 2025

Pacer Advisors Inc. Purchases 115,102 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 27, 2025
pulisher
Jan 21, 2025

Perpetual Ltd Sells 81,043 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Lmcg Investments LLC Takes $5.60 Million Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

MassMutual Private Wealth & Trust FSB Has $2.19 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

2,442 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Aaron Wealth Advisors LLC - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Arkadios Wealth Advisors Invests $716,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 21, 2025
pulisher
Jan 19, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Short Interest Update - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

Kera Capital Partners Inc. Buys New Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 19, 2025
pulisher
Jan 18, 2025

Wedge Capital Management L L P NC Sells 48,679 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Empirical Asset Management LLC Invests $5.36 Million in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 17, 2025
pulisher
Jan 16, 2025

Hennion & Walsh Asset Management Inc. Has $4.42 Million Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Burney Co. Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 16, 2025
pulisher
Jan 15, 2025

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey

Jan 15, 2025
pulisher
Jan 15, 2025

JAZZ (Jazz Pharmaceuticals) Growth Rank : 7 (As of Jan. 15, 2025) - GuruFocus.com

Jan 15, 2025
pulisher
Jan 15, 2025

Jazz Pharmaceuticals plc (JAZZ): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey

Jan 15, 2025
pulisher
Jan 14, 2025

Serina Therapeutics Appoints Former Jazz Pharmaceuticals Finance Executive Karen Wilson to Board - StockTitan

Jan 14, 2025
pulisher
Jan 13, 2025

Acute Lymphocytic Leukemia Pipeline Analysis 2024: FDA - openPR

Jan 13, 2025
pulisher
Jan 12, 2025

With EPS Growth And More, Jazz Pharmaceuticals (NASDAQ:JAZZ) Makes An Interesting Case - Simply Wall St

Jan 12, 2025
pulisher
Jan 06, 2025

Jazz Pharmaceuticals CEO sells shares worth $185,145 By Investing.com - Investing.com Nigeria

Jan 06, 2025
pulisher
Jan 06, 2025

Insider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Sells 1,500 Shares of Stock - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Jazz Pharmaceuticals CEO sells shares worth $185,145 - Investing.com India

Jan 06, 2025
pulisher
Jan 03, 2025

Centre Asset Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $177.00 Consensus Target Price from Analysts - MarketBeat

Jan 03, 2025
pulisher
Jan 01, 2025

JPMorgan Chase & Co. Lowers Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 01, 2025
pulisher
Dec 28, 2024

Principal Financial Group Inc. Sells 66,821 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 28, 2024
pulisher
Dec 25, 2024

Sentiment Still Eluding Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Simply Wall St

Dec 25, 2024
pulisher
Dec 23, 2024

Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 (NASDAQ:JAZZ) - Seeking Alpha

Dec 23, 2024
pulisher
Dec 23, 2024

Drug Resistant Epilepsy Market Growth, Trends & Key Players - openPR

Dec 23, 2024
pulisher
Dec 22, 2024

Barclays PLC Has $4.37 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 22, 2024
pulisher
Dec 21, 2024

Sanctuary Advisors LLC Acquires 9,804 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 21, 2024
pulisher
Dec 18, 2024

Akari Therapeutics Names Interim CEO Patel as Permanent Chief, Adds Jazz Pharma Veteran to Board - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

Jazz Pharmaceuticals CEO to retire by end 2025, search begins - Investing.com Australia

Dec 18, 2024
pulisher
Dec 18, 2024

Public Employees Retirement System of Ohio Makes New $2.49 Million Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Dec 18, 2024
pulisher
Dec 17, 2024

Jazz Pharmaceuticals CEO to Present Strategic Vision at JP Morgan Healthcare Conference 2025 - StockTitan

Dec 17, 2024
pulisher
Dec 17, 2024

Big Peninsula drugmaker on the hunt for new CEO - The Business Journals

Dec 17, 2024
pulisher
Dec 17, 2024

Jazz Pharmaceuticals CEO to Retire, Succession Search Underway - Sleep Review

Dec 17, 2024
pulisher
Dec 17, 2024

Graft-Versus-Host Disease Market on Track for Major Expansion - openPR

Dec 17, 2024
pulisher
Dec 17, 2024

Jazz Pharmaceuticals Announces CEO Succession Plan - PharmiWeb.com

Dec 17, 2024
pulisher
Dec 17, 2024

Jazz Pharmaceuticals CEO to retire - MSN

Dec 17, 2024
pulisher
Dec 16, 2024

Bruce Cozadd to retire as Jazz’s CEO - BioCentury

Dec 16, 2024
pulisher
Dec 16, 2024

Bruce Cozadd to Retire as Chief Executive Officer of Jazz Pharmaceuticals plc Upon Appointment of Successor by the End of 2025 - Marketscreener.com

Dec 16, 2024
pulisher
Dec 16, 2024

Jazz Pharmaceuticals CEO to retire by end of 2025 - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 16, 2024

Jazz to search for new chief as CEO plans retirement - BioPharma Dive

Dec 16, 2024

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
大文字化:     |  ボリューム (24 時間):